dc.contributor.author | IRVINE, ALAN | en |
dc.date.accessioned | 2010-11-15T13:47:11Z | |
dc.date.available | 2010-11-15T13:47:11Z | |
dc.date.issued | 2009 | en |
dc.date.submitted | 2009 | en |
dc.identifier.citation | Rodriguez S, Hall AJ, Granell R, McLean WH, Irvine AD, Palmer CN, Smith GD, Henderson J, Day IN, Carrier status for the common R501X and 2282del4 filaggrin mutations is not associated with hearing phenotypes in 5,377 children from the ALSPAC cohort, PLoS ONE, 4, 6, 2009, e5784 | en |
dc.identifier.other | Y | en |
dc.description | PUBLISHED | en |
dc.description.abstract | Background: Filaggrin is a major protein in the epidermis. Several mutations in the filaggrin gene (FLG) have been associated with a number of conditions. Filaggrin is expressed in the tympanic membrane and could alter its mechanical properties, but the relationship between genetic variation in FLG and hearing has not yet been tested. Methodology/Principal Findings: We examined whether loss-of function mutations R501X and 2282del4 in the FLG gene affected hearing in children. Twenty eight hearing variables representing five different aspects of hearing at age nine years in 5,377 children from the Avon Longitudinal Study of Parents and Children (ALSPAC) cohort were tested for association with these mutations. No evidence of association was found between R501X or 2282del4 (or overall FLG mutation carrier status) and any of the hearing phenotypes analysed. Conclusions/Significance: In conclusion, carrier status for common filaggrin mutations does not affect hearing in children. | en |
dc.description.sponsorship | The UK Medical Research Council, the Wellcome Trust and the University of Bristol provide core support for ALSPAC. Measurements of hearing ability were supported by the core support for ALSPAC. The genotyping was supported by a grant from Tenovus (Tayside) to CP. CP is supported by the Chief Scientists Office of the Scottish Executive Generation Scotland Initiative. The McLean laboratory is supported by grants from British Skin Foundation/National Eczema Association, The Pachyonychia Congenita Project and The Dystrophic Epidermolysis Bullosa Research Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. | en |
dc.format.extent | e5784 | en |
dc.language.iso | en | en |
dc.relation.ispartofseries | PLoS ONE | en |
dc.relation.ispartofseries | 4 | en |
dc.relation.ispartofseries | 6 | en |
dc.rights | Y | en |
dc.subject | Epidemiology | en |
dc.subject | phenotypes | en |
dc.title | Carrier status for the common R501X and 2282del4 filaggrin mutations is not associated with hearing phenotypes in 5,377 children from the ALSPAC cohort | en |
dc.type | Journal Article | en |
dc.type.supercollection | scholarly_publications | en |
dc.type.supercollection | refereed_publications | en |
dc.identifier.peoplefinderurl | http://people.tcd.ie/irvinea | en |
dc.identifier.rssinternalid | 60843 | en |
dc.identifier.rssuri | http://dx.doi.org/10.1371/journal.pone.0005784 | en |
dc.identifier.uri | http://hdl.handle.net/2262/41160 | |